Role of HbA1c and duration of diabetes in predicting mortality in patients of diabetic ketoacidosis in type II diabetes mellitus

Authors

  • Srishti Sonwani Department of Medicine, BMC Sagar, Sagar, Madhya Pradesh, India
  • Sutakshee Sonwani Department of Medicine, GRMC Gwalior, Gwalior, Madhya Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20192891

Keywords:

Diabetic ketoacidosis, Mortality, Prognostic factor, Type 2 diabetes mellitus

Abstract

Background: Previous studies have reported the presence of diabetes ketoacidosis in patients of type 2 diabetes mellitus (T2DM). India reported that up to 30% of hospitalized DKA cases result in inpatient death. Aims and objectives of the study was to study the role of HbA1c and duration of diabetes in outcome of patients of diabetic ketoacidosis in type 2 diabetes mellitus.

Methods: Hundred T2DM patients having DKA admitted in the Department of Medicine, Gandhi Medical College and Hamidia Hospital, Bhopal, were included. Data on demography (age, sex and diabetes duration, random blood sugar (RBS) and glycated hemoglobin (HbA1c) were recorded for each patients. Outcome was also recorded and compared with duration of diabetes and HbA1c level.

Results: DKA was more common in age group of51-55 years (21%) with mean age of 56.10±10.40 years. Male preponderance was observed. Mean duration of diabetes, hemoglobin, random blood sugar (RBS) and HbA1c were 7.28±3.81 years, 9.8±1.42 gm%, 351.72±22.32 mg/dl, and 7.14±0.10 respectively. Mortality was higher among the patients with longer duration of diabetes (23.1%; p=0.012) and higher HbA1c (25%, p>0.05).

Conclusions: Duration of diabetes play a significant role in deciding mortality in T2DM patients with DKA however HbA1c has no role in that.

References

International Diabetes Foundation. Diabetes: facts and figures. Available at: http://www.idf.org/WDD15-guide/facts-and-figures.html. Accessed on 2019 March 15.

DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992 Mar 1;15(3):318-68.

Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet. 2008 May 24;371(9626):1800-9.

Lin MV, Bishop G, Benito-Herrero M. Diabetic Ketoacidosis in Type 2 Diabetics: A Novel Presentation of Pancreatic Adenocarcinoma. J Gen Intern Med. 2010;25(4):369-73.

Westphal SA. The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med. 1996;101(1):19-24.

Selvin E, Steffes MW, Zhu H. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800-11.

Khaw KT, Wareham N, Luben R. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) BMJ. 2001;322:15-8.

Venkatesh B, Pilcher D, Prins J, Bellomo R, Morgan TJ, Bailey M. Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand. Crit Care. 2015;19:451-8.

Liu CC, Chen KR, Chen HF, Huang HL, Ko MC, Li CY. Trends in hospitalization for diabetic ketoacidosis in diabetic patients in Taiwan: analysis of national claims data, 1997-2005. J Formos Med Assoc. 2010;109:725-34.

Kitabchi AE, Fisher JN, Murphy MB. Diabetic ketoacidosis and hyperglycaemic hyperosmolar state. In: De Fronzo RA, Ferrannini E, Keen H, Zimmet P, editors. International Textbook of Diabetes Mellitus. 3rd ed. Chichester, UK: John Wiley and Sons; 2004:1101.

Le Neveu F, Hywel B, Harvey JN. Euglycaemic ketoacidosis in patients with and without diabetes. Pract Diabetes. 2013:30:167-71.

Gibb FW, Teoh WL, Graham J, Lockman KA. Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia. 2016:59;2082-7.

Kruljac I, Ćaćić M, Ćaćić P, Biloš LS, Ostojić V, Blaslov K, et al. All-cause mortality prognostic factors in type 2 diabetes-associated ketosis and ketoacidosis. Endocrine Oncol Metabol. 2018;4(1):12-22.

Sreekumar ST, Sugeeth MT, Kumar KGS, Vijayakumar M. Diabetic Ketoacidosis Clinical Profile, Precipitating Events, Metabolic Abnormalities and Correlation with Treatment Outcome. Sch J App Med Sci. 2017; 5(11A):4302-5.

Elmehdawi RR, Ehmida M, Elmagrehi H, Alaysh A. Incidence and mortality of Diabetic ketoacidosis in Benghazi-Libya in 2007. Oman Med J. 2013;28(3):178-83.

Weinstock RS, Xing D, Maahs DM. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab. 2013;98:3411-9.

Downloads

Published

2019-06-28

How to Cite

Sonwani, S., & Sonwani, S. (2019). Role of HbA1c and duration of diabetes in predicting mortality in patients of diabetic ketoacidosis in type II diabetes mellitus. International Journal of Research in Medical Sciences, 7(7), 2631–2633. https://doi.org/10.18203/2320-6012.ijrms20192891

Issue

Section

Original Research Articles